Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Q1 2026 Update: Tecan on track…
Funding is awarded following successful completion of IND-enabling studies and clinical study authorization USD 6 million in additional funding to support…
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, July 08, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a…